Skip to main content
. 2020 Oct 12;75:104243. doi: 10.1016/j.jff.2020.104243

Fig. 8.

Fig. 8

SARS-COV-2 pathway. (A, B) KEGG enrichment analysis from the potential targets. (C) Distribution of SFJDC targets which related to immunomodulatory and anti-inflammatory pathways.